236 related articles for article (PubMed ID: 27178681)
1. ASCO Plenary Sessions: impact, legacy, future.
Vandross A; Prasad V; Mailankody S
Semin Oncol; 2016 Jun; 43(3):321-6. PubMed ID: 27178681
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology 41st annual meeting.
Dillman RO
Expert Opin Biol Ther; 2005 Aug; 5(8):1117-27. PubMed ID: 16050788
[TBL] [Abstract][Full Text] [Related]
3. Updates of adjuvant therapy in pancreatic cancer: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
Li J; Merl MY; Chabot J; Saif MW
JOP; 2010 Jul; 11(4):310-2. PubMed ID: 20601799
[TBL] [Abstract][Full Text] [Related]
4. A report from the 47th Annual Meeting of the American Society of Clinical Oncology (June 3-7, 2011 - Chicago, Illinois, USA).
Rabasseda X; Gómez-Zaera M
Drugs Today (Barc); 2011 Sep; 47(9):693-737. PubMed ID: 21971543
[TBL] [Abstract][Full Text] [Related]
5. Plenary presentations and public citations from The American Association for Thoracic Surgery.
Kamel M; Terasaki Y; Adusumilli PS; Stiles BM
J Thorac Cardiovasc Surg; 2016 Jan; 151(1):30-4. PubMed ID: 26421982
[TBL] [Abstract][Full Text] [Related]
6. Scientific impact of Association for Academic Surgery and Society of University Surgeons plenary session abstracts increases in the era of the Academic Surgical Congress from 2006 to 2010.
Kaifi JT; Kibbe MR; LeMaire SA; Staveley-O'Carroll KF; Kao LS; Sosa JA; Kimchi ET; Pawlik TM; Gusani NJ
J Surg Res; 2013 Jun; 182(1):6-10. PubMed ID: 22954524
[TBL] [Abstract][Full Text] [Related]
7. American Society of Clinical Oncology--34th Annual Meeting. Treatments for prostate cancer and new molecular targets. 16-19 May 1998, Los Angeles, California, USA.
McKinnon C
IDrugs; 1998 Jun; 1(2):163-7. PubMed ID: 18465522
[TBL] [Abstract][Full Text] [Related]
8. Pattern of Duplicate Presentations at National Hematology-Oncology Meetings: Influence of the Pharmaceutical Industry.
Ramchandren R; Schiffer CA
J Oncol Pract; 2016 Mar; 12(3):254-9, 252-3. PubMed ID: 26349954
[TBL] [Abstract][Full Text] [Related]
9. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
[TBL] [Abstract][Full Text] [Related]
10. Neuro-oncology: a selected review of ASCO 2011 abstracts.
Chamberlain MC
Expert Rev Neurother; 2011 Oct; 11(10):1371-7. PubMed ID: 21955193
[TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology (ASCO) - 55th Annual Meeting (May 31-June 4, 2019 - Chicago, Illinois, USA).
Kibble A; Kuenneman K; de Las Heras Prat P
Drugs Today (Barc); 2019 Jun; 55(6):407-415. PubMed ID: 31250844
[TBL] [Abstract][Full Text] [Related]
12. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
14. Gene therapy and immunotherapy.
McKinnon C
IDrugs; 1999 Jul; 2(7):620-3. PubMed ID: 16127624
[TBL] [Abstract][Full Text] [Related]
15. Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
Bezjak A; Temin S; Franklin G; Giaccone G; Govindan R; Johnson ML; Rimner A; Schneider BJ; Strawn J; Azzoli CG
J Clin Oncol; 2015 Jun; 33(18):2100-5. PubMed ID: 25944914
[TBL] [Abstract][Full Text] [Related]
16. How do U.S. medical oncologists learn and apply new clinical trials information from press releases in nonmedical media? A case study based on ECOG 4599.
Dornbusch D; Allegra C; Willey J; Andrews M; Leff R; Epstein J; Jones J; Lokey L; Green MR
Oncologist; 2006 Jan; 11(1):31-8. PubMed ID: 16401711
[TBL] [Abstract][Full Text] [Related]
17. Gender Representation Among Plenary Panel Speakers at the American Urological Association Annual Meeting.
Harris KT; Clifton MM; Matlaga BR; Koo K
Urology; 2021 Apr; 150():54-58. PubMed ID: 32592762
[TBL] [Abstract][Full Text] [Related]
18. From presentation to paper: Gender disparities in oncological research.
Dijksterhuis WPM; Stroes CI; Tan WL; Ithimakin S; Calles A; van Oijen MGH; Verhoeven RHA; Barriuso J; Oosting SF; Ivankovic DK; Furness AJS; Bozovic-Spasojevic I; Gomez-Roca C; van Laarhoven HWM
Int J Cancer; 2020 Jun; 146(11):3011-3021. PubMed ID: 31472016
[TBL] [Abstract][Full Text] [Related]
19. Paradigm change in urological, gynaecological and breast cancer management: A new practice-changing data from ASCO 2022 annual meeting.
Andrif M; Elmarrachi H; Ismaili N
Cancer Treat Res Commun; 2023; 35():100677. PubMed ID: 36696853
[TBL] [Abstract][Full Text] [Related]
20. Novel agents in the treatment of unresectable neuroendocrine tumors. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
Oberstein PE; Saif MW
JOP; 2011 Jul; 12(4):358-61. PubMed ID: 21737896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
